Transfusion support in liver transplantation.

[1]  H. Metselaar,et al.  Increased tissue‐type plasminogen activator activity in orthotopic but not heterotopic liver transplantation: The role of the anhepatic period , 1992, Hepatology.

[2]  T. Duvall,et al.  The Rapid Infusion System. , 1991, Surgical technology international.

[3]  H. Grosse,et al.  Coagulation disorder during liver transplantation , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[4]  R. Porte,et al.  Hemostasis in liver transplantation. , 1989, Gastroenterology.

[5]  T. Starzl,et al.  Liver transplantation: Intraoperative changes in coagulation factors in 100 first transplants , 1989, Hepatology.

[6]  T. Gasior,et al.  Prognostic Significance of Reperfusion Hyperglycemia during Liver Transplantation , 1989, Anesthesia and analgesia.

[7]  W. Dzik,et al.  Citrate toxicity during massive blood transfusion. , 1988, Transfusion medicine reviews.

[8]  R. Jenkins,et al.  Fibrinolysis during liver transplantation in humans: role of tissue-type plasminogen activator. , 1988, Blood.

[9]  M. Burritt,et al.  Ionized calcium monitoring during liver transplantation. , 1987, Archives of pathology & laboratory medicine.

[10]  T. Starzl,et al.  Epsilon‐aminocaproic Acid for Treatment of Fibrinolysis during Liver Transplantation , 1987, Anesthesiology.

[11]  T. Simon,et al.  Effects of AS‐3 nutrient‐additive solution on 42 and 49 days of storage of red cells , 1987, Transfusion.

[12]  M. Pinsky,et al.  Cardiovascular Depression Secondary to Ionic Hypocalcemia during Hepatic Transplantation in Humans , 1986, Anesthesiology.

[13]  B. Buckley,et al.  Plasma ionized calcium monitoring during liver transplantation. , 1986, Transplantation.

[14]  D. V. van Thiel,et al.  THE RELATION OF PREOPERATIVE COAGULATION FINDINGS TO DIAGNOSIS, BLOOD USAGE, AND SURVIVAL IN ADULT LIVER TRANSPLANTATION , 1985, Transplantation.

[15]  F. Carmichael,et al.  Anesthesia for Hepatic Transplantation: Cardiovascular and Metabolic Alterations and their Management , 1985, Anesthesia and analgesia.

[16]  I. Nilsson,et al.  Shelf‐life of bank blood and stored plasma with special reference to coagulation factors , 1983, Transfusion.

[17]  F. Weirich,et al.  Chemical and hematologic changes in stored CPDA‐1 blood , 1982, Transfusion.

[18]  M. Chopek,et al.  Therapeutic Plasma Exchange , 1981 .

[19]  T. Zuck,et al.  Some Properties of Blood Stored in Anticoagulant CPDA‐1 Solution. A Brief Summary , 1981, Transfusion.

[20]  J. Aldrete,et al.  Anesthetic implications in hepatic transplantation. , 1981, Contemporary anesthesia practice.

[21]  T. Simon,et al.  Hemostasis in Massively Transfused Trauma Patients , 1979, Annals of surgery.

[22]  R. Horton,et al.  Studies of renin and aldosterone in cirrhotic patients with ascites. , 1975, Gastroenterology.

[23]  Collins Ja.  Problems associated with the massive transfusion of stored blood. , 1974 .